
Royal Philips Electronics (AEX: PHI, NYSE: PHG) has published its Annual Report for 2008. In 2008, Philips Healthcare's sales amounted to EUR 7,649 million, 15% higher than in 2007 on a nominal basis, largely thanks to the contributions from acquired companies, notably Respironics. Excluding the 14% positive impact of portfolio changes and the 5% unfavorable impact of currency effects, comparable sales grew 6%.